default author photo

Fanghui Zhao

Chinese Academy of Medical Sciences - National Cancer Center

Beijing

China

Chinese Academy of Medical Sciences - Peking Union Medical College

NO. 9, Dongdan Santiao

Beijing, Dongcheng District

China

SCHOLARLY PAPERS

3

DOWNLOADS

184

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

Feasibility and Safety of an HPV-Based 'See-and-Treat' Approach with Thermal Ablation for Cervical Cancer Prevention in Rural China: Baseline Evaluation from a Prospective Study

Number of pages: 24 Posted: 19 Feb 2019
Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - National Cancer Center, Capital Medical University - Beijing Tongren Hospital, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences - National Cancer Center, RTI International - RTI International, New Delhi, Chinese Academy of Medical Sciences - National Cancer Center and World Health Organization (WHO) - International Agency for Research on Cancer (IARC)
Downloads 92 (730,864)
Citation 2

Abstract:

Loading...

HPV test, Self-collection, Thermal ablation, See-and-Treat, Cervical Cancer

2.

Naturally Acquired Antibodies Against Human Papillomavirus are Protective Against Subsequent Homotypic Infection: A Large-Scale Prospective Cohort Study

Number of pages: 58 Posted: 16 Feb 2021
Xiamen University, Chinese Academy of Medical Sciences - Department of Cancer Epidemiology, Peking University People's Hospital, Peking University - Department of Obstetrics and Gynecology, Jiangsu Provincial Center for Disease Control and Prevention, Peking University People's Hospital, Xiamen Innovax Biotech Company, Xiamen Innovax Biotech Company, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Nanjing University - The Affiliated Drum Tower Hospital, Shenzhen Maternity and Child Healthcare Hospital, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chinese Academy of Medical Sciences - National Cancer Center, Peking University, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen University, Chinese Academy of Medical Sciences - National Cancer Center, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen Innovax Biotech Company, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - School of Population Medicine and Public Health, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics
Downloads 55 (1,010,164)

Abstract:

Loading...

3.

The Additional Health and Economic Benefits of HPV Vaccination in China from Preventing HPV-Related Non-Cervical Cancers: A Modeling Study

Number of pages: 46 Posted: 03 May 2026
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Government of the People's Republic of China - China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) and Chinese Academy of Medical Sciences - National Cancer Center
Downloads 37 (1,236,159)

Abstract:

Loading...

Human papillomavirus vaccination, non-cervical cancer, health impacts, cost-effectiveness, modeling study